2020 U.S.-Booked Air Volume: $12 million
Consolidated U.S. TMC: CWT
Novartis reported revenues for the fiscal year 2020, ended
Dec. 31, 2020, of $48.7 million, compared with $47.4 million reported in fiscal
year 2019, a 3 percent increase. Net income was down about 31 percent from 2019
to $8.1 billion. BTN estimates that the company’s U.S.-booked air volume
dropped from an estimate of $100 million in 2019 to $12 million in 2020, due to
the Covid-19 pandemic.
Among Novartis’ recent acquisitions is neuroscience company
Cadent Therapeutics, announced in December 2020, and in May 2021 the company
signed a collaboration agreement and option to acquire Cellerys, which is
working on a therapy to fight multiple sclerosis.
The company reported Scope 3 greenhouse gas emissions
related to business travel in 2020 as 27 metric tons, down from 191.3 metric
tons reported in 2019. Novartis employed approximately 106,000 full-time
individuals as of Dec. 31, 2020, an increase of about 2,000 from the year
prior.